Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
I see Altria benefiting from the shift to smoke-free products as the NJOY and on! brands gain volume while cigarette sales fall. NJOY's device shipments tripled in Q3 2024 with the FDA approving its menthol e-cigarettes, improving its market share to 6.2%. The proliferation of illicit e-vapor products and the ongoing patent fight with Juul pose significant risks to Altria's market share and growth.
The stock has a very attractive yield.
Asness's AQR Capital Management disposed of almost its entire stake in artificial intelligence (AI) titan Taiwan Semi in favor of an industry-leading company that was sporting a 9% yield.
Dividend Raises: Four companies in my "Rose's Income Garden" portfolio raised dividends, with Mondelez leading at 10.6% and Altria offering the highest yield at 7.5%. Investment Analysis: Philip Morris, Altria, Mondelez, and WP Carey are evaluated for their dividends, earnings, and Chowder numbers, with Rose recommendations based on valuation and growth potential. Portfolio Performance: "Rose's Income Garden" portfolio yields 6.5% and has outperformed the SPY by 5.72% since November 2021, emphasizing income and value.
Altria Group, Inc.'s strong financial performance, new product traction, and compelling valuation support a “Strong Buy” rating, with a safe 7.6% forward dividend yield. Recent earnings showed positive revenue and EPS surprises, with NJOY and on! nicotine pouches demonstrating significant growth and consumer satisfaction. The “Optimize & Accelerate” initiative aims to streamline operations and achieve $600 million in cost savings, reinforcing Altria's robust fundamentals.
Altria Group stock has outperformed the market and its peers, as my bullish thesis played out accordingly. The market will likely focus next on Altria's ability to carve out its market leadership in smokeless products. MO's valuation metrics have narrowed relative to its sector peers and long-term averages.
[00:00:00] Doug McIntyre: They want to talk a little bit about inflation.
At first glance, Altria might look like a safe dividend stock -- but that's far from the case.
Altria stock surged 7.83% after beating Q3 earnings expectations, with 1.3% net revenue growth and 7.8% adjusted EPS growth. The company has long-term growth potential through smoke-free products like NJOY and rewards shareholder via dividends and buybacks in the meantime. Altria announced a cost-saving initiative called "Optimize & Accelerate," which is expected to save the company at least $600 million over the next five years.
Smoking doesn't align with my personal values.
The market was clearly impressed how management is coping with the company's challenging situation.